9MFN | pdb_00009mfn

Crystal Structure of ADI-64596 (human Fab, with substituted IgG1-CH1 (HC-L145Q, K147E, and S181E) and substituted kappa constant domain (LC-T129R, T178R, and T180Q))

External Resource: Annotation

SAbDab Antibody Annotation
Thera-SAbDab Antibody Annotation
Protein Modification Annotation

SAbDab Antibody Annotation SAbDab Database Homepage

Chain	Chain Class	Chain Subclass	Chain Type	Antigen Name(s)	Provenance Source
B [auth L]	Light Chain	IGKV1	Kappa	-	SAbDab (2025-12-19)
A [auth H]	Heavy Chain	IGHV4	-	-	SAbDab (2025-12-19)

Thera-SAbDab Antibody Annotation Thera-SAbDab Database Homepage

Chain	Name	Target	Provenance Source
B [auth L]	Demupitamab	EGFR/ERBB1/HER1, MET/HGFR	Therapeutic SAbDab (2025-12-19)
A [auth H]	Demupitamab	EGFR/ERBB1/HER1, MET/HGFR	Therapeutic SAbDab (2025-12-19)

Protein Modification Annotation

Modified Residue(s)
Chain	Residue(s)	Description
A [auth H]	PCA	Parent Component: GLN RESID: AA0031 PSI-MOD : 2-pyrrolidone-5-carboxylic acid (Gln) MOD:00040 , 2-pyrrolidone-5-carboxylic acid (Glu) MOD:00420

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.